Cochrane Abstracts
Haloperidol discontinuation for people with schizophrenia New
Haloperidol discontinuation for people with schizophrenia New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Haloperidol Discontinuation for People With Schizophrenia New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439038/all/Haloperidol_discontinuation_for_people_with_schizophrenia_New. Accessed 28 May 2022.
Haloperidol discontinuation for people with schizophrenia New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439038/all/Haloperidol_discontinuation_for_people_with_schizophrenia_New. Accessed May 28, 2022.
Haloperidol discontinuation for people with schizophrenia New. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439038/all/Haloperidol_discontinuation_for_people_with_schizophrenia_New
Haloperidol Discontinuation for People With Schizophrenia New [Internet]. In: Cochrane Abstracts. [cited 2022 May 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439038/all/Haloperidol_discontinuation_for_people_with_schizophrenia_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol discontinuation for people with schizophrenia New
ID - 439038
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439038/all/Haloperidol_discontinuation_for_people_with_schizophrenia_New
DB - Evidence Central
DP - Unbound Medicine
ER -
